secwatch.observer — SEC 8-K summary
======================================

Issuer:     BIODESIX INC (BDSX)
CIK:        0001439725
Form:       8-K
Filed at:   2025-04-17T23:59:59+00:00
Accession:  0001193125-25-084319
Event type: leadership
Sentiment:  neutral
Materiality: 0.40
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Two Biodesix directors resign effective May 20, 2025; Schuler named director emeritus
--------------------------------------------------------------------------------

- Charles Watts, M.D. resigns from Board and Compensation Committee effective at 2025 Annual Meeting (May 20, 2025).
- Jack Schuler resigns from Board and Nominating & Corporate Governance Committee, transitions to director emeritus (non-voting advisory role).
- Both resignations not due to any disagreement with Company's operations, policies, or practices.
- Dr. Watts served since July 2019; Mr. Schuler served since June 2008.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1439725/000119312525084319/0001193125-25-084319-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1439725/000119312525084319/d861784d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-084319

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer